B. Przyklenk
Impact in
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
-
- Cystic Fibrosis Research Advances
- Tracheal and airway disorders
- Inhalation and Respiratory Drug Delivery
- Neonatal Respiratory Health Research
Papers in ⓘ
-
- Cystic Fibrosis Research Advances 10
- Inhalation and Respiratory Drug Delivery 3
-
- Antifungal resistance and susceptibility 5
- Antimicrobial Resistance in Staphylococcus 2
- Co-authors
- A. Bauernfeind (17 shared papers)Gerd Hörl (6 shared papers)Gerd Döring (2 shared papers)Félix Ratjen (2 shared papers)H. von der Hardt (2 shared papers)Gratiana Steinkamp (2 shared papers)Karsten Harms (4 shared papers)R. Jungwirth (2 shared papers)
- Journals
- Infection (8 papers)Pediatric Pulmonology (2 papers)Scandinavian Journal of Gastroenterology (2 papers)Shock (1 paper)Serodiagnosis and Immunotherapy in Infectious Disease (3 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
B. Przyklenk
16 papers receiving 369 citations
Peers
Comparison fields: 5 of 50
- Molecular Medicine 60
- Pulmonary and Respiratory Medicine 280
- Endocrinology 35
- Infectious Diseases 80
- Critical Care and Intensive Care Medicine 20
Countries citing papers authored by B. Przyklenk
This map shows the geographic impact of B. Przyklenk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Przyklenk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Przyklenk more than expected).
Fields of papers citing papers by B. Przyklenk
This network shows the impact of papers produced by B. Przyklenk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Przyklenk. The network helps show where B. Przyklenk may publish in the future.
Co-authors
The 16 scholars most cited alongside B. Przyklenk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 152 | |
| 2 | 1987 | 118 | |
| 3 | 1987 | 27 | |
| 4 | 1990 | 23 | |
| 5 | 1988 | 10 | |
| 6 | 1987 | 9 | |
| 7 | 1998 | 9 | |
| 8 | 1987 | 7 | |
| 9 | 1989 | 7 | |
| 10 | 1990 | 6 | |
| 11 | 1990 | 5 | |
| 12 | 1988 | 5 | |
| 13 | 1988 | 5 | |
| 14 | Microbiological background for anti-Pseudomonas aeruginosa vaccination in cystic fibrosis. | 1997 | 4 |
| 15 | 1990 | 4 | |
| 16 | 1987 | 3 | |
| 17 | [Antibacterial antibodies in immunoglobulins]. | 1985 | 1 |
| 18 | 1997 | 1 |
About B. Przyklenk
B. Przyklenk is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases, Molecular Biology, Molecular Medicine and Epidemiology, having authored 18 papers that have together received 396 indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (10 papers), Bacterial biofilms and quorum sensing (5 papers), Antifungal resistance and susceptibility (5 papers), Antibiotic Resistance in Bacteria (5 papers), Inhalation and Respiratory Drug Delivery (3 papers), Helicobacter pylori-related gastroenterology studies (3 papers), Antimicrobial Resistance in Staphylococcus (2 papers) and Eosinophilic Esophagitis (2 papers). The work is most often cited by research in Molecular Medicine (60 citations), Pulmonary and Respiratory Medicine (280 citations), Endocrinology (35 citations), Infectious Diseases (80 citations) and Critical Care and Intensive Care Medicine (20 citations). B. Przyklenk has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include A. Bauernfeind, Gerd Hörl, Gerd Döring, Félix Ratjen, H. von der Hardt, Gratiana Steinkamp, Karsten Harms, R. Jungwirth, C. Petermüller and Richard V. Goering. Their work appears in journals such as Infection, Pediatric Pulmonology, Scandinavian Journal of Gastroenterology, Shock and Serodiagnosis and Immunotherapy in Infectious Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.